bms-214662
Showing 1 - 6 of 6
Solid Tumor Trial in Boston (BMS-214662, laboratory biomarker analysis, pharmacological study)
Completed
- Unspecified Adult Solid Tumor, Protocol Specific
- BMS-214662
- +2 more
-
Boston, MassachusettsDana-Farber Cancer Institute
Jan 31, 2013
Solid Tumor, Child Solid Tumor Trial in Houston (BMS-214662, laboratory biomarker analysis)
Completed
- Unspecified Adult Solid Tumor, Protocol Specific
- Unspecified Childhood Solid Tumor, Protocol Specific
- BMS-214662
- laboratory biomarker analysis
-
Houston, TexasM D Anderson Cancer Center
Jan 22, 2013
Solid Tumor Trial in Philadelphia (drug, biological, other)
Completed
- Unspecified Adult Solid Tumor, Protocol Specific
- BMS-214662
- +2 more
-
Philadelphia, PennsylvaniaFox Chase Cancer Center
Jan 24, 2013
Adult Acute Promyelocytic Leukemia (M3), Blastic Phase Chronic Myelogenous Leukemia, Childhood MDS Trial in Houston (BMS-214662,
Completed
- Adult Acute Promyelocytic Leukemia (M3)
- +10 more
- BMS-214662
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Jan 22, 2013
Solid Tumor Trial in Cleveland, Columbus (BMS-214662, paclitaxel)
Completed
- Unspecified Adult Solid Tumor, Protocol Specific
- BMS-214662
- paclitaxel
-
Cleveland, Ohio
- +1 more
Jun 10, 2010
Solid Tumor Trial in New York (BMS-214662)
Completed
- Unspecified Adult Solid Tumor, Protocol Specific
- BMS-214662
-
New York, New YorkMemorial Sloan-Kettering Cancer Center
Dec 2, 2009